Kyowa Hakko Bio Co., Ltd., KOHJIN Life Sciences Co., Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd., and Lesaffre are at the forefront, collectively holding a significant share, leveraging expertise in high-purity production, nutraceutical formulations, and large-scale supply chain operations
0.5 cases per 1,000 patient-years)
Our focus on empathy and innovation means we are constantly looking for ways to improve your experience
Patients who are already on Zepbound through Aetna may be able to request a continuity exception to avoid disruption, though this is not guaranteed and depends on the specific employer plan
George, Cedar City, and Salt Lake City, Utah ), we focus on preventing telogen effluvium before it starts by supporting healthy, sustainable weight loss: Reviewing calorie and protein intake to avoid under-fueling Adjusting GLP-1 dosing and pacing to prevent crash physiology Identifying patients at higher risk for nutrient-related shedding (very low intake, heavy menstrual bleeding, prior bariatric surgery, restrictive diets) Using targeted lab testing only when clinically indicated to identify correctable deficiencies Providing nutrition and side-effect guidance so weight loss stays steady, not extreme Bottom line Hair shedding during Wegovy or Zepbound treatment is not a drug side effect it is usually a sign that weight loss or nutrition has become too aggressive for the body